1.7-million Americans will pick up infections at the hospital this year, often antibiotic resistant superbugs hard to disinfect, that can potentially be fatal.
That has apparently happened to an eight-year-old Westlake boy. During the time he was receiving chemotherapy for his brain cancer, he got C. diff. , a superbug that kills one in ten people who get it, and lingers on surfaces for months. But Aydan Chapman is safely home now, his entire house disinfected by a superbug zapping robot.
The San Antonio based company Xenex recently sold its disinfecting robots to St. Davids in Austin. Within minutes, they can disinfect a hospital room for anything from Ebola, C. diff. MRSA, norovirus, even Anthrax.
Also this fall, Aydan Chapman learned that he had acquired c-Diff, around the time of his chemo treatment at Dell Children’s Medical Center. Dell confirmed the infection. Aydan had already endured four brain tumors since 2009, now he is enduring chemo and strong antibiotics for the superbug.
Bryce Chapman, Aydan’s father, is hearing impaired but told KXAN through a Community Service for the Deaf sign reader, “It was extremely frustrating to see what was happening with him. It was actually two to three weeks before we learned he had the c-Diff, so he had gone through so much at this point. It felt like he was getting hit by more than one thing.”
To read article in its entirety click on the following link:
Guests: Dr. Mark Stibich, PhD, is Chief Scientific Officer & Co-founder, Xenex. and
Ms. Sarah Simmons, MPH CIC, is Science Director, Xenex
Dr. Stibich and Ms. Simmons will discuss UV Room Disinfection, how pulsed UV disinfection works, the pulsed Xenon UV (PX-UV) difference, and the effectiveness against endospores like
C. diff. and bacillus strains and the scientific evidence in eliminating
Healthcare-Associated Infections worldwide.
Dr. Mark Stibich, PhD, Chief Scientific Officer & Co-founder, Xenex
Dr. Stibich is a founder of Xenex and, as its Chief Scientific Officer, he oversees scientific research, product development, facility assessments, and protocol design. He leads new technology development and is an inventor on multiple patents. Dr. Stibich meets frequently with infection prevention representatives at healthcare facilities, helping them understand and solve their infection control challenges while analyzing hospital results. Dr. Stibich holds a doctoral degree from the Johns Hopkins University School of Public Health, a Masters in Health Science, also from Johns Hopkins, and a bachelor’s degree from Yale University. He has conducted research in Russia, Tajikistan, Afghanistan, South Africa, Kenya, the United States and Brazil.
Ms. Sarah Simmons, Science Director, Xenex
As an epidemiologist, Sarah Simmons works with customers to implement Xenex’s pulsed xenon UV light room disinfection technology in their facility, provide support for customers’ Infection Prevention departments, and evaluate their infection reduction results for publication in scientific journals. Sarah worked as an Infection Preventionist for five years in San Antonio, with a focus on infection prevention in critical care. She is a member of the San Antonio APIC chapter and has served on the board in numerous roles. Sarah is a Doctoral Candidate at the University of Texas School of Public Health, has a Masters of Public Health in Epidemiology and Biostatistics from the Texas A&M School of Rural Public Health, and a Bachelors degree in Biology from Texas A&M University.